Integrated insulin delivery system having safety features to prevent hypoglycemia
US11185632B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2020 |
| Grant date | Nov 30, 2021 |
| Priority date | — |
| Expiry date | Aug 12, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/201
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Systems comprising: an analyte sensor for providing an analyte signal representative of an analyte level; a controller in data communication with the analyte sensor and programmed to provide a recommended medication dose based on the analyte level and a medication type, the controller comprising a user interface for inputting the medication type; and a model-based safety mechanism integrated with the controller for evaluating the recommended medication dose. Wherein the model-based safety mechanism overrides the recommended medication dose and provides a safety medication dose when the model-based safety mechanism detects a risk of insulin deprivation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.